申请人:Hoechst-Roussel Pharmaceuticals Inc.
公开号:US04623657A1
公开(公告)日:1986-11-18
There are described compounds of the formula ##STR1## where each X is independently H, halogen, loweralkyl, loweralkoxy or OH; m is 1 or 2; and R is --H, .dbd.O, ##STR2## .dbd.CH(CH.sub.2).sub.n NR.sub.1 CH.sub.3, --CH.sub.2 (CH.sub.2).sub.n NR.sub.1 R.sub.2, .dbd.N--OH, .dbd.N--OCH.sub.2 (CH.sub.2).sub.n NR.sub.1 R.sub.3, ##STR3## .dbd.N--OCH.sub.2 CHOHCH.sub.2 NR.sub.1 R.sub.3, --NR.sub.2 R.sub.3, --OH or --OCH.sub.2 (CH.sub.2).sub.n NR.sub.1 R.sub.2, n being 1 or 2, R.sub.1 being loweralkyl, R.sub.2 being H, loweralkyl, loweralkanoyl, arylloweralkyl, arylloweralkanoyl, diarylloweralkyl, diarylloweralkanoyl, --CO.sub.2 C.sub.2 H.sub.5 or --CN, and R.sub.3 being H, loweralkyl, arylloweralkyl or diarylloweralkyl, or a pharmaceutically acceptable acid addition salt thereof, which are useful as antihypertensive, anticonvulsant, analgesic and antidepressant agents.
描述了以下化合物的化学式##STR1##,其中每个X独立地是H、卤素、较低烷基、较低烷氧基或OH;m为1或2;R为--H、.dbd.O、##STR2## .dbd.CH(CH.sub.2).sub.n NR.sub.1 CH.sub.3、--CH.sub.2 (CH.sub.2).sub.n NR.sub.1 R.sub.2、.dbd.N--OH、.dbd.N--OCH.sub.2 (CH.sub.2).sub.n NR.sub.1 R.sub.3、##STR3## .dbd.N--OCH.sub.2 CHOHCH.sub.2 NR.sub.1 R.sub.3、--NR.sub.2 R.sub.3、--OH或--OCH.sub.2 (CH.sub.2).sub.n NR.sub.1 R.sub.2,其中n为1或2,R.sub.1为较低烷基,R.sub.2为H、较低烷基、较低烷酰基、芳基较低烷基、芳基较低烷酰基、二芳基较低烷基、二芳基较低烷酰基、--CO.sub.2 C.sub.2 H.sub.5或--CN,R.sub.3为H、较低烷基、芳基较低烷基或二芳基较低烷基,或其药学上可接受的酸盐,可用作抗高血压、抗癫痫、镇痛和抗抑郁药物。